Al-Dawaa Medical Services Company
TADAWUL:4163.SR
95 (SAR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,586.272 | 1,516.42 | 1,458.087 | 1,438.946 | 1,436.739 | 1,407.592 | 1,458.3 | 1,308.93 | 1,310.191 | 1,294.821 | 1,298.341 | 1,259.558 | 1,266.768 | 1,209.715 | 1,240.929 | 1,240.929 | 1,303.837 | 1,240.109 |
Cost of Revenue
| 1,010.301 | 951.997 | 932.998 | 918.035 | 911.097 | 872.615 | 924.61 | 823.986 | 803.402 | 800.646 | 765.257 | 808.172 | 808.79 | 757.758 | 803.898 | 803.898 | 773.076 | 751.562 |
Gross Profit
| 575.971 | 564.423 | 525.09 | 520.911 | 525.642 | 534.976 | 533.69 | 484.944 | 506.789 | 494.175 | 533.084 | 451.386 | 457.977 | 451.956 | 437.031 | 437.031 | 530.762 | 488.547 |
Gross Profit Ratio
| 0.363 | 0.372 | 0.36 | 0.362 | 0.366 | 0.38 | 0.366 | 0.37 | 0.387 | 0.382 | 0.411 | 0.358 | 0.362 | 0.374 | 0.352 | 0.352 | 0.407 | 0.394 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 33.786 | 35.385 | -54.269 | 34.298 | 26.136 | 35.574 | -42.304 | 28.085 | 34.449 | 31.989 | -47.095 | 35.898 | 36.686 | 26.072 | 23.716 | 23.716 | 28.283 | 27.735 |
Selling & Marketing Expenses
| 405.877 | 396.263 | -919.141 | 384.622 | 377.465 | 384.438 | -935.678 | 374.172 | 381.788 | 391.472 | -862.92 | 364.681 | 354.379 | 351.534 | 325.89 | 325.89 | 370.819 | 349.244 |
SG&A
| 439.664 | 431.648 | -973.41 | 418.921 | 403.601 | 420.012 | -977.982 | 402.257 | 416.237 | 423.461 | -910.015 | 400.579 | 391.066 | 377.606 | 353.675 | 353.675 | 399.101 | 376.979 |
Other Expenses
| -441.673 | -433.93 | -397.395 | 1.751 | -0.298 | -0.139 | -7.674 | -0.571 | 3.276 | 4.304 | -13.62 | 0.979 | 2.56 | 1.976 | 0 | 0 | 0 | 0 |
Operating Expenses
| 441.673 | 433.93 | 397.395 | 418.921 | 403.601 | 420.012 | 403.297 | 402.257 | 416.237 | 423.461 | 452.118 | 400.579 | 391.066 | 377.606 | 292.723 | 292.723 | 456.78 | 431.454 |
Operating Income
| 134.298 | 130.493 | 127.695 | 101.99 | 122.041 | 114.964 | 125.085 | 82.687 | 90.552 | 70.714 | 75.824 | 50.807 | 66.911 | 74.351 | 83.357 | 83.357 | 131.66 | 111.568 |
Operating Income Ratio
| 0.085 | 0.086 | 0.088 | 0.071 | 0.085 | 0.082 | 0.086 | 0.063 | 0.069 | 0.055 | 0.058 | 0.04 | 0.053 | 0.061 | 0.067 | 0.067 | 0.101 | 0.09 |
Total Other Income Expenses Net
| -134.298 | -130.493 | -127.695 | -28.172 | -28.447 | -35.179 | -30.151 | -31.533 | -7.881 | 18.395 | -8.876 | -10.014 | -10.472 | 7.487 | 4.461 | 4.461 | -72.31 | -68.839 |
Income Before Tax
| 103.913 | 98.793 | 95.206 | 73.819 | 93.594 | 79.785 | 94.934 | 51.154 | 82.672 | 89.109 | 66.948 | 40.794 | 56.439 | 81.837 | 87.817 | 87.817 | 59.351 | 42.73 |
Income Before Tax Ratio
| 0.066 | 0.065 | 0.065 | 0.051 | 0.065 | 0.057 | 0.065 | 0.039 | 0.063 | 0.069 | 0.052 | 0.032 | 0.045 | 0.068 | 0.071 | 0.071 | 0.046 | 0.034 |
Income Tax Expense
| 8.035 | 3.465 | 2.855 | 2.535 | 4.26 | 3.53 | 5.421 | 3 | 2 | 2 | -2.127 | 2.5 | 3.5 | 3 | 3.829 | 3.829 | 4 | 3.5 |
Net Income
| 95.878 | 95.328 | 92.351 | 71.283 | 89.334 | 76.255 | 89.514 | 48.154 | 80.672 | 87.109 | 69.075 | 38.294 | 52.939 | 78.837 | 83.988 | 83.988 | 55.351 | 39.23 |
Net Income Ratio
| 0.06 | 0.063 | 0.063 | 0.05 | 0.062 | 0.054 | 0.061 | 0.037 | 0.062 | 0.067 | 0.053 | 0.03 | 0.042 | 0.065 | 0.068 | 0.068 | 0.042 | 0.032 |
EPS
| 1.13 | 1.12 | 1.09 | 0.84 | 1.05 | 0.9 | 1.05 | 0.57 | 0.95 | 1.02 | 0.81 | 0.45 | 0.62 | 0.93 | 0.55 | 0.55 | 3.32 | 2.35 |
EPS Diluted
| 1.13 | 1.12 | 1.09 | 0.84 | 1.05 | 0.9 | 1.05 | 0.57 | 0.95 | 1.02 | 0.81 | 0.45 | 0.62 | 0.93 | 0.55 | 0.55 | 3.32 | 2.35 |
EBITDA
| 227.992 | 223.038 | 221.258 | 196.325 | 215.98 | 203.801 | 204.612 | 170.579 | 184.572 | 172.325 | 150.451 | 136.677 | 154.26 | 154.89 | 118.263 | 118.263 | 168.315 | 148.223 |
EBITDA Ratio
| 0.144 | 0.147 | 0.152 | 0.136 | 0.15 | 0.145 | 0.14 | 0.13 | 0.141 | 0.133 | 0.116 | 0.109 | 0.122 | 0.128 | 0.095 | 0.095 | 0.129 | 0.12 |